Background Investigation Methods, Corporate Intelligence & Due Diligence, e-Discovery Techniques, Investigation & Intelligence Feeds, Judgment Enforcement, Legal Enforcement Cases, Legal Ethics & Intelligence, Legal Technology & Intelligence, Witness Credibility Analysis

JPM 2026: FDA panelists prioritize faster approvals, national security, AI, and more

Posted by author-avatar
0
Test Logo Transparent

Speaking at the 2026 J.P. Morgan Healthcare Conference, Hogan Lovells global regulatory partners Elizabeth Jungman and Brian Carey moderated a panel discussion with U.S. Food and Drug Administration (FDA) Deputy Chief of Staff Samuel Doran and FDA Office of the Commissioner Senior Advisor Karim Mikhail….
By: Hogan Lovells

Newer
Innovation Within Limits, January 2026 – Insured State Member Banks Receive Support to Engage in Crypto-Asset Activities
Back to list
Older Supreme Court Grants Cert. Petition in Hikma / Amarin Skinny Labeling Case

Leave a Reply

Your email address will not be published. Required fields are marked *